31st Annual Cutaneous Malignancy Update - Melanoma 2021


Melanoma: Art and Science, Yesterday and Today

Dr. James Patterson discusses the history of melanoma diagnosis and treatment.
James Patterson, MD

James Patterson, MD

Professor of Pathology and Dermatology
Division of Surgical Pathology & Cytopathology
University of Virginia School of Medicine

Pathology of Melanoma: Current Status and Prognostic Indicators

Dr. Cora Humberson discusses the important prognostic factors when diagnosing malignant melanoma.
Cora Humberson, MD

Cora Humberson, MD

Dermatopathology Coordinator
Department of Pathology
Scripps Clinic

Dermoscopy and New Diagnostic Techniques

Dr. Travis Blalock summarizes the benefits of dermoscopy in aiding clinicians in the diagnosis of melanoma using visual examples to assist learners in identifying the difference between malignant and benign lesions.
Travis Blalock, MD

Travis Blalock, MD

Assistant Professor of Dermatology
Director, Dermatologic Surgery, Mohs Micrographic Surgery and Cutaneous Oncology
Director, Micrographic Surgery and Dermatologic Oncology Fellowship
Emory University School of Medicine

The Role of UV Radiation and Exposure in Melanoma

Dr. Ashley Wysong offers a review of the effect of ultraviolet rays on the skin and how it contributes to the development of melanoma.
Ashley Wysong, MD, MS

Ashley Wysong, MD, MS

Founding Chair and Associate Professor
William W. Bruce, M.D. Distinguished Chair of Dermatology
University of Nebraska Medical Center

Moles and Melanoma in Kids

Dr. Caroline Piggott addresses moles in children including a discussion of benign lesions as well as worrisome lesions that may need further diagnostic work up.
Caroline Piggot, MD

Caroline Piggot, MD

Adult and Pediatric Dermatology
Scripps Clinic

Dysplastic Nevi

Dr. Benjamin Kelley covers the risk that dysplastic nevi play in melanoma including assessing and treating atypical nevi as the sole diagnosis.
Benjamin Kelley, MD

Benjamin Kelley, MD

Mohs Micrographic Surgeon
Bighorn Mohs Surgery and Dermatology Center

Sentinel Node Evaluation

Dr. Merrick Ross provides an overview of the indications and logistics involved with sentinel lymph node biopsy as it relates to diagnosis and management of melanoma.
Merrick Ross, MD

Merrick Ross, MD

Professor, Department of Surgical Oncology, Chief, Melanoma Section
Charles M. McBride Distinguished Chair, Department of Surgical Oncology
UT MD Anderson Cancer Center

Ocular and Periocular Melanoma

Dr. Geva Mannor discusses the risk and relation of melanoma of the eye as a stand-alone diagnosis and how it relates to the cutaneous manifestation.
Geva Mannor, MD, MPH

Geva Mannor, MD, MPH

Oculoplastic Surgeon
Division of Ophthalmology
Scripps Clinic

Melanoma: Head and Neck Surgeon’s Perspective

Dr. Brendan Gaylis outlines the risks and complications of melanoma in the head and neck region.
Brendan Gaylis, MD

Brendan Gaylis, MD

Facial Plastic & Reconstructive Surgery
Scripps Clinic

Neoadjuvant Therapy for Advanced Resectable Melanoma

Dr. Merrick Ross discusses immunotherapy as a modality to use prior to or in conjunction with surgery as a pathway to combat melanoma.
Merrick Ross, MD

Merrick Ross, MD

Professor, Department of Surgical Oncology, Chief, Melanoma Section
Charles M. McBride Distinguished Chair, Department of Surgical Oncology
UT MD Anderson Cancer Center

Radiation Therapy for Melanoma Including Lentigo Maligna

Dr. Prabhakar Tripuraneni discusses the role and efficacy of radiation for treating melanoma.
Prabhakar Tripuraneni, MD

Prabhakar Tripuraneni, MD

Director, Radiation Oncology
Scripps Clinic

Evaluation of Melanonychia

Dr. Frederick Fish outlines how to obtain a pathologic specimen from the sometimes difficult location of the peri and subungual region.
Frederick Fish, III, MD

Frederick Fish, III, MD

Mohs Surgeon
Associated Skin Care Specialists

Melanoma, the Primary Lesion: Biopsy, Excision and Mohs Surgery in Selected Cases

Dr. Ashley Wysong reviews proper biopsy choice and excision techniques when melanoma is suspected.
Ashley Wysong, MD, MS

Ashley Wysong, MD, MS

Founding Chair and Associate Professor
William W. Bruce, M.D. Distinguished Chair of Dermatology
University of Nebraska Medical Center

Metastatic Evaluation of the Melanoma Patient

Dr. Douglas Winstanley discusses the pertinent lab and imaging needed to appropriately evaluate early and advanced stage melanoma patients.
Douglas Winstanley, DO

Douglas Winstanley, DO

Clinical Assistant Professor, Michigan State University
Mohs Surgeon, West Michigan Dermatology
Spectrum Health

Treatment of Advanced Melanoma

Dr. Kathryn Bollin outlines evolving role of immunotherapy as well as the efficacy and role of traditional systemic treatments for melanoma.
Kathryn Bollin, MD

Kathryn Bollin, MD

Associate Fellowship Program Director, Division of Hematology & Oncology
Scripps MD Anderson Cancer Center

Melanoma in the Molecular Age Part 1: New Tools for Diagnosis, Prognosis

Dr. Kathleen Murphy outlines new tools for diagnosis and prognosis of melanoma and how this can be applied to personalized medicine.
Kathleen Murphy, PhD

Kathleen Murphy, PhD

Director, Molecular Diagnostics
Chief Laboratory Officer
ProPath

Oncolytic Immunotherapy

Dr. Merrick Ross outlines the expanding role of oncolytic immunotherapy in the treatment of melanoma.
Merrick Ross, MD

Merrick Ross, MD

Professor, Department of Surgical Oncology, Chief, Melanoma Section
Charles M. McBride Distinguished Chair, Department of Surgical Oncology
UT MD Anderson Cancer Center

Melanoma in the Molecular Age Part 2: New Tools for Diagnosis, Prognosis

Dr. Gregory Hosler expands upon Dr. Murphy’s lecture to further explore tools for diagnosis and prognosis of melanoma and applications to personalized medicine.
Gregory Hosler, MD, PhD

Gregory Hosler, MD, PhD

Director of Dermatopathology
ProPath
Clinical Professor
The University of Texas Southwestern Medical Center

Melanoma: Medical Legal Complications

Attorney Robert Cosgrove uses real life case scenarios to demonstrate when the diagnosis of melanoma had a legal impact.
Robert Cosgrove, ESQ

Robert Cosgrove, ESQ

Attorney, Managing Partner
Robert A. Cosgrove & Associates

Cutaneous Toxicities of Immune Therapy

Dr. Aleksandr Itkin summarizes the possible signs and symptoms of cutaneous toxicity which can result from the use of medications used to treat melanoma.
Aleksandr Itkin, MD

Aleksandr Itkin, MD

Division of Dermatology
Scripps MD Anderson Cancer Center

Evaluation of the Melanoma Patient for Other Primary Melanoma Lesions

Dr. Frederick Fish reviews the increased risk previously diagnosed melanoma patients face for developing new lesions while noting modalities that should be used to survey for new primary melanomas.
Frederick Fish, III, MD

Frederick Fish, III, MD

Mohs Surgeon
Associated Skin Care Specialists

Return to Main Menu »

Course Overview

As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course, nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients. Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.

Educational Objectives

  • Demonstrate how newly discovered, evidence-based scientific information applies to the current practice of clinical dermatology.
  • Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma
  • Examine current data and new strategies for the prevention of melanoma.

Target Audience

  • Dermatologists
  • Pathologists
  • Dermatopathologists
  • Primary Care Physicians
  • Dermatology Nurses/Nurse Practitioners/Physician Assistants

View Faculty Disclosures »